Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro is taken once a week — a single subcutaneous injection, same day each week, every week. That weekly rhythm is set by the medicine's licensed schedule, and sticking to it is one of the most practical things you can do to get the most from treatment. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist made by Eli Lilly, and the once-weekly design reflects how long the active ingredient stays in your system. As a prescription-only medicine, it's prescribed following an individual clinical assessment — a prescriber works with you to set the right dose and pace.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people starting Mounjaro ask the same practical question before anything else: do I really take this just once? Yes. One injection, one day per week. Pick a day that fits your life (a Sunday evening, a Friday morning) and keep it consistent. The half-life of tirzepatide means a steady weekly rhythm gives the most stable concentration in your bloodstream, which matters both for tolerability and for how well it works over time.
The pen itself delivers four doses, one per week, so a single Mounjaro KwikPen covers a full four-week supply. You store it in the fridge between doses. A quick habit worth building early: check the expiry and the remaining-dose indicator on the pen before each injection, rather than on injection day itself. Thirty seconds the night before can save a scramble on the morning.
If you ever find yourself wondering whether two injections in a short period could speed things along, the straightforward answer is no, and the reasons why taking Mounjaro more than once a week would be unsafe are worth understanding clearly. The weekly gap is not arbitrary; it is built into the pharmacokinetics of the medicine.
The first dose you take (2.5 mg) is not where most of the clinical effect happens. Its job is to let your body adjust to the medicine before the dose rises. Think of it as your system finding its footing, not as the treatment in full effect yet. After roughly four weeks at 2.5 mg, a prescriber will typically consider moving to 5 mg, and steps continue from there, each separated by at least four weeks.
The transition around week five is often when people begin to notice a clearer change, because by that point most are at or moving toward a therapeutic maintenance dose. Results from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at the highest doses over 72 weeks, meaningful, but achieved gradually across months, not in the first few injections.
The prescriber decides whether each step up is right for you. If side effects are still settling at a given dose, it is reasonable to stay there longer before increasing. What does not change is the once-weekly injection day, that stays fixed regardless of where you are in the titration sequence. For a closer look at what the early weeks tend to feel like week by week, the week six point is often when tolerance has meaningfully improved for most people.
Life doesn't always cooperate with a fixed schedule. If you miss a dose or need to take it a day or two early or late, the Patient Information Leaflet sets out exactly what to do, and that leaflet, alongside your prescriber's advice, is always the right place to check. We won't reproduce those instructions here because they depend on how far outside the window you are, and getting it wrong matters.
What's worth knowing in principle: a single delayed dose does not undo weeks of progress. Mounjaro's long half-life gives some forgiveness. You then resume your usual weekly day and carry on. What you shouldn't do is compress two injections into a short gap to compensate, that is not how the schedule is designed, and doing so increases the risk of side effects without adding therapeutic benefit.
If you're considering a planned pause for surgery, travel or another reason, that's a separate clinical conversation. A prescriber can advise on whether a short break makes sense and how to restart safely. The topic of taking a planned week off Mounjaro is covered in more detail elsewhere on the site, including what the evidence says about briefly pausing treatment.
The most commonly reported side effects of Mounjaro are gastrointestinal: nausea is the one people mention most, along with looser stools, constipation, indigestion and, for some people, unusual belching. These tend to be most noticeable in the days immediately following an injection or a dose increase, and for most people they ease within a week or two as the body adjusts.
The NHS tirzepatide patient information page covers the full side-effect profile, and the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is where you'd report anything unexpected. For context on what treatment costs in the private market, Mounjaro pricing in the UK is explained separately, including what a legitimate price should cover.
If you think Mounjaro may be suitable for you and want to find out from a prescriber rather than a search engine, checking your eligibility with our clinical team is the straightforward next step. A GPhC-registered prescriber (a real clinician, reading your answers on the same day) will assess whether it's appropriate and, if so, which starting dose fits your circumstances.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.